详情页 - 河北大学附属医院知识库

资源类型：

文章类型：

作者：

Wang, Jie[1] * ; Zhong, Jia[2] ; Wu, Lin[3] ; Chen, Bolin[4] ; Wang, Zhe-Hai[5] ; Yao, Yu[6] ; Dong, Xiaorong[7] ; Li, Wei[8] ; Ren, Xiubao[9] ; Hou, Xiaoming[10] ; Zang, Ai-min[11]

; Qu, Xiujuan[12] ; Zhang, Guojun[13] ; Wang, Yongsheng[14] ; Bai, Yuansong[15] ; Liu, Linlin[16] ; Yu, Guohua[17] ; Chen, Xingwu[18] ; Ding, Lieming[19] ;

机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China [2]Hunan Canc Hosp, Changsha, Peoples R China [3]Cent South Univ, Xiangya Sch Med, Thorac Med Dept 2, Affiliated Canc Hosp, Changsha, Peoples R China [4]Cent South Univ, Hunan Canc Hosp, Changsha, Peoples R China [5]Shandong Canc Hosp & Inst, Jinan, Peoples R China [6]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [7]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [8]Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China [9]Tianjin Canc Inst & Hosp, Tianjin, Peoples R China [10]Lanzhou Univ, Dept Med Oncol, Hosp 1, Lanzhou, Peoples R China [11]Hebei Univ, Affiliated Hosp, Baoding, Peoples R China [12]China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China [13]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China [14]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [15]Jilin Univ, Dept Hematol & Oncol, China Japan Union Hosp, Changchun, Peoples R China [16]Jilin Univ, China Japan Union Hosp, Changchun, Peoples R China [17]Weifang Peoples Hosp, Weifang, Shandong, Peoples R China [18]Yijishan Hosp, Affiliated Hosp 1, Wannan Med Coll, Wuhu, Peoples R China [19]Betta Pharmaceut Co Ltd, Hangzhou, Peoples R China

出处：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2025]版：

无

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Efficacy and safety of MCLA-129, an EGFR/c-MET bispecific antibody, in advanced non-small cell lung cancer (NSCLC)

文献详情